在儿科血友病中,定期用激活型前列红素复合物缩剂进行预防
Ayumi Horiguchi1, Yuki Arakawa1, Yuichi Mitani1
1Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
概括
定期使用激活前列红素复合物缩剂 (aPCC) 进行预防,有效地减少了患有血友病和抑制剂的儿童的出血. 虽然通常是安全的,但性综合征的一例突显了需要仔细监测的必要性.
科学领域:
- 儿科血液学 儿科血液学
- 血友病治疗方法 血友病治疗方法
- 凝血障碍 凝血障碍 凝血障碍
背景情况:
- 活性型前列红素复合物缩剂 (aPCC) 是有效的对成年人血友病预防.
- 关于aPCCs在患有血友病抑制剂的儿科患者的预防方面存在有限的数据.
研究的目的:
- 评估定期aPCCs在患有血友病和抑制剂的儿童中预防的疗效和安全性.
- 评估aPCCs对该儿科群体年均出血率 (ABR) 的影响.
主要方法:
- 单中心回顾性研究,包括9名患有严重/中度血友病和抑制剂的儿科患者 (<15岁).
- 患者接受了预防性aPCC (50-100U/kg,每周2-3次).
- 检查了医疗记录,以评估ABR和不良事件.
主要成果:
- 预防性aPCCs治疗 (中位数为13个月) 将中位数ABR降低到2 (范围为0-17).
- 与按需治疗相比,四名患者的ABR减少了19%-100%.
- 一名患者在开始预防治疗34个月后出现了性综合征.
结论:
- 定期的aPCCs预防在患有血友病A和B的幼儿中有效降低ABR.
- 性综合征是一种潜在的严重不良事件,需要在aPCCs治疗期间仔细监测.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
166
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
166
Disorders of Hemostasis
831
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
831
Extrinsic and Intrinsic Pathways of Hemostasis
7.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.0K
Formation of the Platelet Plug
5.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.7K
Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K


